Correspondingly, systemic administration of hypo-exosomes inhibited apoptosis of CMC through inhibition of proapoptotic genes p53 and bcl2-antagonist/killer 1 (BAK1) and consequently improved ischemic heart repair in the rodent MI model [94]. This evidence concerns the gene BAK1 and myocardial infarction.